We moved from lab scale to pilot production with consistent particle size and encapsulation efficiency
More serious but less common risks include pancreatitis (characterized by severe abdominal pain that may radiate to the back), gallbladder disease, and acute kidney injury from volume depletion
This means that is not well studied currently, there is no reliable information on the safety and side effects of microdosing GLP-1, and there are no guidelines on how microdosing should occur
But theres a lot of other things in the universe that the earth supplies. Peptide proponents often suggest their products are safe because they are based on substances found in the body
Skipping doses or starting higher increases the risk of severe nausea, vomiting, and other gastrointestinal side effects that could derail the entire switch
Cell Death Dis 13(7):613 Zhang J, Liu M, Huang M et al (2019) Ginsenoside F1 promotes angiogenesis by activating the IGF-1/IGF1R pathway